Suppr超能文献

转铁蛋白及转铁蛋白受体在脑屏障系统中的功能。

Transferrin and transferrin receptor function in brain barrier systems.

作者信息

Moos T, Morgan E H

机构信息

Department of Medical Anatomy, Panum Institute, University of Copenhagen, Denmark.

出版信息

Cell Mol Neurobiol. 2000 Feb;20(1):77-95. doi: 10.1023/a:1006948027674.

Abstract
  1. Iron (Fe) is an essential component of virtually all types of cells and organisms. In plasma and interstitial fluids, Fe is carried by transferrin. Iron-containing transferrin has a high affinity for the transferrin receptor, which is present on all cells with a requirement for Fe. The degree of expression of transferrin receptors on most types of cells is determined by the level of Fe supply and their rate of proliferation. 2. The brain, like other organs, requires Fe for metabolic processes and suffers from disturbed function when a Fe deficiency or excess occurs. Hence, the transport of Fe across brain barrier systems must be regulated. The interaction between transferrin and transferrin receptor appears to serve this function in the blood-brain, blood-CSF, and cellular-plasmalemma barriers. Transferrin is present in blood plasma and brain extracellular fluids, and the transferrin receptor is present on brain capillary endothelial cells, choroid plexus epithelial cells, neurons, and probably also glial cells. 3. The rate of Fe transport from plasma to brain is developmentally regulated, peaking in the first few weeks of postnatal life in the rat, after which it decreases rapidly to low values. Two mechanisms for Fe transport across the blood-brain barrier have been proposed. One is that the Fe-transferrin complex is transported intact across the capillary wall by receptor-mediated transcytosis. In the second, Fe transport is the result of receptor-mediated endocytosis of Fe-transferrin by capillary endothelial cells, followed by release of Fe from transferrin within the cell, recycling of transferrin to the blood, and transport of Fe into the brain. Current evidence indicates that although some transcytosis of transferrin does occur, the amount is quantitatively insufficient to account for the rate of Fe transport, and the majority of Fe transport probably occurs by the second of the above mechanisms. 4. An additional route of Fe and transferrin transport from the blood to the brain is via the blood-CSF barrier and from the CSF into the brain. Iron-containing transferrin is transported through the blood-CSF barrier by a mechanism that appears to be regulated by developmental stage and iron status. The transfer of transferrin from blood to CSF is higher than that of albumin, which may be due to the presence of transferrin receptors on choroid plexus epithelial cells so that transferrin can be transported across the cells by a receptor-mediated process as well as by nonselective mechanisms. 5. Transferrin receptors have been detected in neurons in vivo and in cultured glial cells. Transferrin is present in the brain interstitial fluid, and it is generally assumed that Fe which transverses the blood-brain barrier is rapidly bound by brain transferrin and can then be taken up by receptor-mediated endocytosis in brain cells. The uptake of transferrin-bound Fe by neurons and glial cells is probably regulated by the number of transferrin receptors present on cells, which changes during development and in conditions with an altered iron status. 6. This review focuses on the information available on the functions of transferrin and transferrin receptor with respect to Fe transport across the blood-brain and blood-CSF barriers and the cell membranes of neurons and glial cells.
摘要
  1. 铁(Fe)几乎是所有类型细胞和生物体的必需成分。在血浆和组织液中,铁由转铁蛋白携带。含铁的转铁蛋白对转铁蛋白受体具有高亲和力,转铁蛋白受体存在于所有需要铁的细胞上。大多数类型细胞上转铁蛋白受体的表达程度由铁供应水平及其增殖速率决定。2. 大脑与其他器官一样,代谢过程需要铁,当铁缺乏或过量时功能会受到干扰。因此,铁穿过脑屏障系统的运输必须受到调节。转铁蛋白与转铁蛋白受体之间的相互作用似乎在血脑屏障、血脑脊液屏障和细胞浆膜屏障中发挥此功能。转铁蛋白存在于血浆和脑细胞外液中,转铁蛋白受体存在于脑毛细血管内皮细胞、脉络丛上皮细胞、神经元以及可能还有神经胶质细胞上。3. 从血浆到脑的铁运输速率受发育调节,在大鼠出生后的头几周达到峰值,之后迅速下降至低值。已提出两种铁穿过血脑屏障的运输机制。一种是铁 - 转铁蛋白复合物通过受体介导的转胞吞作用完整地穿过毛细血管壁。另一种是铁运输是毛细血管内皮细胞对铁 - 转铁蛋白进行受体介导的内吞作用的结果,随后铁在细胞内从转铁蛋白中释放出来,转铁蛋白循环回血液,铁运输到脑内。目前的证据表明,虽然转铁蛋白确实会发生一些转胞吞作用,但数量在定量上不足以解释铁运输的速率,并且大多数铁运输可能通过上述第二种机制发生。4. 铁和转铁蛋白从血液到脑的另一条运输途径是通过血脑脊液屏障并从脑脊液进入脑。含铁的转铁蛋白通过一种似乎受发育阶段和铁状态调节的机制运输穿过血脑脊液屏障。转铁蛋白从血液到脑脊液的转运高于白蛋白,这可能是由于脉络丛上皮细胞上存在转铁蛋白受体,使得转铁蛋白可以通过受体介导的过程以及非选择性机制跨细胞运输。5. 已在体内神经元和培养的神经胶质细胞中检测到转铁蛋白受体。转铁蛋白存在于脑间质液中,一般认为穿过血脑屏障的铁会迅速与脑转铁蛋白结合,然后可通过脑细胞中的受体介导的内吞作用被摄取。神经元和神经胶质细胞对转铁蛋白结合铁的摄取可能受细胞上存在的转铁蛋白受体数量调节,该数量在发育过程中和铁状态改变的情况下会发生变化。6. 本综述重点关注关于转铁蛋白和转铁蛋白受体在铁穿过血脑屏障和血脑脊液屏障以及神经元和神经胶质细胞膜的运输方面的现有信息。

相似文献

1
Transferrin and transferrin receptor function in brain barrier systems.
Cell Mol Neurobiol. 2000 Feb;20(1):77-95. doi: 10.1023/a:1006948027674.
2
Brain iron homeostasis.
Dan Med Bull. 2002 Nov;49(4):279-301.
3
Transport of iron in the blood-brain-cerebrospinal fluid system.
J Neurochem. 1997 Aug;69(2):443-54. doi: 10.1046/j.1471-4159.1997.69020443.x.
4
Iron trafficking inside the brain.
J Neurochem. 2007 Dec;103(5):1730-40. doi: 10.1111/j.1471-4159.2007.04976.x. Epub 2007 Oct 22.
5
Efflux of iron from the cerebrospinal fluid to the blood at the blood-CSF barrier: effect of manganese exposure.
Exp Biol Med (Maywood). 2008 Dec;233(12):1561-71. doi: 10.3181/0803-RM-104. Epub 2008 Oct 10.
7
Mechanism and developmental changes in iron transport across the blood-brain barrier.
Dev Neurosci. 2002;24(2-3):106-13. doi: 10.1159/000065699.
8
Studies of the mechanism of iron transport across the blood-brain barrier.
Ann Neurol. 1992;32 Suppl:S43-50. doi: 10.1002/ana.410320709.
10
Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system.
Neuroscience. 2003;121(4):883-90. doi: 10.1016/s0306-4522(03)00590-6.

引用本文的文献

1
NFIA-dependent upregulation of SMC4 promotes metastasis and metabolic reprogramming in glioma.
Front Oncol. 2025 Aug 25;15:1624370. doi: 10.3389/fonc.2025.1624370. eCollection 2025.
3
Transformative Impact of Nanocarrier-Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons.
Small Sci. 2024 Sep 17;4(11):2400280. doi: 10.1002/smsc.202400280. eCollection 2024 Nov.
6
Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities.
Neuroprotection. 2024 Sep;2(3):182-195. doi: 10.1002/nep3.56. Epub 2024 Sep 15.
7
Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials.
Neural Regen Res. 2025 Aug 1;20(8):2245-2263. doi: 10.4103/NRR.NRR-D-24-00025. Epub 2024 Jul 29.
8
A commentary on studies of brain iron accumulation during ageing.
J Biol Inorg Chem. 2024 Jun;29(4):385-394. doi: 10.1007/s00775-024-02060-2. Epub 2024 May 12.

本文引用的文献

1
2
Synthesis of plasma proteins by rat fetal brain and choroid plexus.
Int J Dev Neurosci. 1984;2(3):215-22. doi: 10.1016/0736-5748(84)90015-7.
3
Transferrin in fetal rat brain and cerebrospinal fluid.
Int J Dev Neurosci. 1983;1(6):369-73. doi: 10.1016/0736-5748(83)90018-7.
4
Kinetics and distribution of [59Fe-125I]transferrin injected into the ventricular system of the rat.
Brain Res. 1998 Apr 20;790(1-2):115-28. doi: 10.1016/s0006-8993(98)00055-9.
5
Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells.
Am J Physiol. 1996 Apr;270(4 Pt 2):H1149-58. doi: 10.1152/ajpheart.1996.270.4.H1149.
7
Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease.
Nat Med. 1996 Nov;2(11):1230-5. doi: 10.1038/nm1196-1230.
9
Cultured leptomeningeal cells secrete cerebrospinal fluid proteins.
J Neurochem. 1996 Sep;67(3):964-71. doi: 10.1046/j.1471-4159.1996.67030964.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验